Societe de Promotion Pharmaceutique du Maghreb S.A. (CBSE: PRO)

Morocco flag Morocco · Delayed Price · Currency is MAD
990.00
0.00 (0.00%)
At close: Jan 22, 2025
4.76%
Market Cap 990.00M
Revenue (ttm) 805.52M
Net Income (ttm) 56.90M
Shares Out 1.00M
EPS (ttm) 56.90
PE Ratio 17.40
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 10
Average Volume 68
Open 990.00
Previous Close n/a
Day's Range 990.00 - 990.00
52-Week Range 873.00 - 1,150.00
Beta -0.09
RSI 55.90
Earnings Date Apr 25, 2025

About CBSE: PRO

Societe de Promotion Pharmaceutique du Maghreb S.A. produces, commercializes, imports, and exports medicines, derma-pharmaceuticals, and cosmetic products in Africa. It subcontracts medicines for national and international laboratories. The company was founded in 1947 and is headquartered in Had-Soualem, Morocco. Societe de Promotion Pharmaceutique du Maghreb S.A. operates as a subsidiary of Hikma Pharmaceuticals PLC. [Read more]

Industry Pharmaceutical Preparations
Founded 1947
Employees 343
Stock Exchange Casablanca Stock Exchange
Ticker Symbol PRO
Full Company Profile

Financial Performance

In 2023, PRO's revenue was 805.52 million, an increase of 14.32% compared to the previous year's 704.64 million. Earnings were 56.90 million, a decrease of -24.42%.

Financial Statements

News

There is no news available yet.